Evidence-Based Treatment

Ritalin (Methylphenidate): Use, Misuse, and Recovery

Ritalin is a methylphenidate stimulant approved for ADHD and narcolepsy. Learn what misuse looks like and how treatment helps.

Speak with a treatment specialist 24/7 Free and confidential. For you, or for someone you're worried about.

Quick summary

Ritalin is methylphenidate, a stimulant the FDA approves as part of total treatment for ADHD and narcolepsy, and its label carries Schedule II status. Methylphenidate misuse is far less common than amphetamine misuse - about 0.3% of US adults in 2023 - and stimulant use disorder is treatable with behavioral therapies such as contingency management and cognitive-behavioral therapy.

Ritalin is the brand name for methylphenidate hydrochloride, a central nervous system stimulant approved as part of a comprehensive treatment plan for attention deficit disorders and for narcolepsy. Its label marks it as a Schedule II controlled substance. Methylphenidate is misused less often than amphetamine products, and stimulant use disorder remains treatable through behavioral care.

A different chemistry from Adderall

Methylphenidate and the amphetamines are both stimulants, but they are different molecules. Large national survey data show the practical difference: past-year misuse of methylphenidate was 0.3% among all US adults in 2023, compared with 1.6% for amphetamine mixed salts, and the gap holds in young adults (1.2% versus 3.7%). A nationally representative study of adults aged 18 to 64 similarly found misuse more than three times higher among people using amphetamine-type medications than among those using methylphenidate.

That difference does not make Ritalin harmless. The label still carries Schedule II status, and misuse of any stimulant at high doses produces the same family of cardiovascular and psychiatric risks.

What the label covers

Ritalin's prescribing information indicates it for attention deficit disorders as part of a total treatment program that typically includes psychological, educational, and social measures - medication is one component, not the whole plan. It is also indicated for narcolepsy. Methylphenidate has been approved in the United States since 1955.

How misuse starts

Most misuse begins with diversion - pills shared or given away rather than sold. Federal data show that among adults who misused prescription stimulants, more than half obtained them free from friends or relatives, and in most of those cases the friend or relative had received them from one physician. Stated motives are mostly practical: wanting to concentrate, stay awake, or keep up with work or school. The survey evidence does not show that stimulants improve grades in people without ADHD.

Risks of taking methylphenidate other than prescribed

NIDA's patient education materials list the effects of misused stimulants: high blood pressure, fast heartbeat, high body temperature, sleep problems, angry reactions, and heart problems. Extended-release tablets are designed to be swallowed whole - crushing them defeats the release mechanism and dumps the full dose into the bloodstream at once.

Over time, misuse can change how the brain works and lead to addiction - continuing a drug even when it causes problems. When someone with a stimulant habit stops, a crash follows: fatigue, dysphoric mood, and low motivation, which make it hard to begin treatment without support.

What treatment looks like

SAMHSA's national protocol for stimulant use disorders is direct: no FDA-approved medication exists, so behavioral care carries the load. Contingency management - reinforcing abstinence with tangible incentives - has the strongest scientific support, followed by cognitive-behavioral therapy, community reinforcement, and motivational interviewing. Case management and coordinated care help people stay engaged.

If this describes you or someone you care about, call or text (800) 653-9376 or complete the form below.

SAMHSA's National Helpline (1-800-662-HELP, 4357) and the FindTreatment.gov locator are free, confidential ways to see what is available near you.

Last updated: Sun Oct 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is Ritalin approved to treat?

Ritalin's FDA labeling indicates it as an integral part of a total treatment program - typically including psychological, educational, and social measures - for attention deficit disorders, and for narcolepsy.

How common is Ritalin misuse compared with Adderall?

A 2023 federal survey found past-year methylphenidate misuse among 0.3% of all US adults and 1.2% of adults aged 19 to 30, compared with 1.6% and 3.7% respectively for amphetamine mixed salts. A nationally representative study also found misuse 3.1 times higher among people using amphetamine-type medications than methylphenidate.

Where do misused prescription stimulants usually come from?

Among adults who misused prescription stimulants, the most common source for the most recent misuse was getting the medication free from friends or relatives (56.9%) - usually someone with a single legitimate prescription.

Is Ritalin addiction treated with medication?

There are currently no FDA-approved medications for any stimulant use disorder, per SAMHSA's Treatment Improvement Protocol. The treatments with the strongest evidence are contingency management, cognitive-behavioral therapy, community reinforcement, and motivational interviewing.

What should I do in an emergency involving stimulants?

Call 911 if someone has chest pain, a seizure, extremely high body temperature, or becomes unresponsive. Naloxone does not reverse stimulant overdose. For a mental health crisis, call or text 988.

Call or text (800) 653-9376 Get help online